Market Place
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services. 
X
Please Wait
Applying Filters...
01 EUROAPI FRANCE (1)
02 Symbiotec Pharmalab Private Limited (1)
03 Curia Spain S.A.U. (1)
04 HENAN LIHUA PHARMACEUTICAL CO., LTD. (1)
05 Pharmacia and Upjohn Company LLC (1)
06 Professional Compounding Centers of America (1)
07 STERLING SPA (1)
08 Spectrum Laboratory Products, Inc. (1)
09 Tianjin Tianyao Pharmaceuticals Co., Ltd. (1)
10 Zhejiang Xianju Pharmaceutical Co., Ltd. (1)
01 METHYLPREDNISOLONE (2)
02 METHYLPREDNISOLONE SODIUM SULEPTANATE (1)
03 METHYLPREDNISOLONE SULEPTANATE (1)
04 Methylprednisolone (6)
01 China (3)
02 France (1)
03 India (1)
04 Italy (1)
05 U.S.A (3)
06 United Kingdom (1)
87
PharmaCompass offers a list of Methylprednisolone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methylprednisolone manufacturer or Methylprednisolone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methylprednisolone manufacturer or Methylprednisolone supplier.
PharmaCompass also assists you with knowing the Methylprednisolone API Price utilized in the formulation of products. Methylprednisolone API Price is not always fixed or binding as the Methylprednisolone Price is obtained through a variety of data sources. The Methylprednisolone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione, including repackagers and relabelers. The FDA regulates 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione supplier is an individual or a company that provides 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione active pharmaceutical ingredient (API) or 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione finished formulations upon request. The 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione suppliers may include 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione API manufacturers, exporters, distributors and traders.
click here to find a list of 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione suppliers with NDC on PharmaCompass.
We have 10 companies offering 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
Get in contact with the supplier of your choice:
